Search

everythinglearnresearchcommunity

for

Search:↓

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

Black women with CCCA are more likely to have uterine fibroids.

Effective alopecia treatment depends on the specific cause and includes medications and procedures.

New hair treatment methods are evolving, with microneedling as a promising technique for hair growth.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

The HoVert technique is a simple, cost-effective new method that improves alopecia diagnosis by allowing detailed analysis from a single biopsy.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

A unique case showed a rare combination of two types of lichen planus on the face.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Lichen planopilaris can be accurately diagnosed and effectively treated.